# Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients

> **NCT07005986** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 20 (estimated)

## Conditions studied

- Type 2 Diabetes
- Type 2 Diabetes Patients

## Interventions

- **DIAGNOSTIC_TEST:** Plasmatic PPi level

## Key facts

- **NCT ID:** NCT07005986
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-18
- **Primary completion:** 2026-07-18
- **Final completion:** 2026-07-18
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07005986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07005986, "Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07005986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*